Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production

Metabolic Engineering

Volumn 19, Issue , 2013, Pages 33-41

  Alonso Gutierrez, Jorge ^a,b   Chan, Rossana ^a,b   Batth, Tanveer S ^a,b   Adams, Paul D ^a,b   Keasling, Jay D ^a,b,c,d   Petzold, Christopher J ^a,b   Lee, Taek Soon ^a,b  

^a JOINT BIOENERGY INSTITUTE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c University of California at Berkeley   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Escherichia coli; Limonene; Metabolic engineering; Mevalonate pathway; Microbial production; Perillyl alcohol

Indexed keywords

ANION EXCHANGE RESINS; COMMODITY CHEMICALS; LIMONENE; MEVALONATE PATHWAY; MICROBIAL PRODUCTION; PERILLYL ALCOHOL; POTENTIAL PRODUCTION; SITU PRODUCT RECOVERY;

ESCHERICHIA COLI; HYDROXYLATION; METABOLIC ENGINEERING; PRODUCTION PLATFORMS;

MONOTERPENES;

ANTINEOPLASTIC AGENT; CYTOCHROME P450; GLUCOSE; LIMONENE; LIMONENE SYNTHASE; MEVALONIC ACID; PERILLYL ALCOHOL; SYNTHETASE; TERPENE; UNCLASSIFIED DRUG;

ALCOHOL PRODUCTION; ANION EXCHANGE; ARTICLE; BACTERIAL STRAIN; ENZYME SYNTHESIS; ESCHERICHIA COLI; HYDROXYLATION; METABOLIC ENGINEERING; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEOMICS;

ESCHERICHIA COLI; LIMONENE; METABOLIC ENGINEERING; MEVALONATE PATHWAY; MICROBIAL PRODUCTION; PERILLYL ALCOHOL;

ANTINEOPLASTIC AGENTS; CYCLOHEXENES; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HYDROXYLATION; METABOLIC ENGINEERING; MEVALONIC ACID; MONOTERPENES; TERPENES;

ESCHERICHIA COLI;

EID: 84879829307     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2013.05.004     Document Type: Article

References (44)

1. Alper H., Miyaoku K., Stephanopoulos G. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat. Biotechnol. 2005, 23:612-616.
2. Anderson J.C., Dueber J.E., Leguia M., Wu G.C., Goler J.A., Arkin A.P., Keasling J.D. BglBricks: a flexible standard for biological part assembly. J. Biol. Eng. 2010, 4:1.
3. Anthony J.R., Anthony L.C., Nowroozi F., Kwon G., Newman J.D., Keasling J.D. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metab. Eng. 2009, 11:13-19.
4. Batth T.S., Keasling J.D., Petzold C.J. Targeted proteomics for metabolic pathway optimization. Methods Mol. Biol. 2012, 944:237-249.
5. Bentley W.E., Mirjalili N., Andersen D.C., Davis R.H., Kompala D.S. Plasmid-encoded protein - the principal factor in the metabolic burden associated with recombinant bacteria. Biotechnol. Bioeng. 1990, 35:668-681.
6. Bomgardner M. Orange crush. Tight-limonene supplies put the squeeze on makers of citrus-based cleaners. Chemical and Engineering News 2011, vol. 89. AMERICAN CHEMICAL SOCIETY, Washington D.C, 21, http://pubs.acs.org/doi/abs/10.1021/cen-v089n014.p021.
7. Boucher Y., Doolittle W.F. The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathways. Mol. Microbiol. 2000, 37:703-716.
8. Burke C., Croteau R. Geranyl diphosphate synthase from Abies grandis: cDNA isolation, functional expression, and characterization. Arch. Biochem. Biophys. 2002, 405:130-136.
9. Calos M.P. DNA-sequence for a low-level promoter of lac repressor gene and an up promoter mutation. Nature 1978, 274:762-765.
10. Casadaban M.J., Cohen S.N. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. Journal of molecular biology 1980, 138:179-207.
11. Chang M.C.Y., Eachus R.A., Trieu W., Ro D.K., Keasling J.D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat. Chem. Biol. 2007, 3:274-277.
12. Connolly D.M., Winkler M.E. Genetic and physiological relationships among the miaA gene, 2-methylthio-N6-(delta 2-isopentenyl)-adenosine tRNA modification, and spontaneous mutagenesis in Escherichia coli K-12. J. Bacteriol. 1989, 171:3233-3246.
13. Dueber J.E., Wu G.C., Malmirchegini G.R., Moon T.S., Petzold C.J., Ullal A.V., Prather K.L.J., Keasling J.D. Synthetic protein scaffolds provide modular control over metabolic flux. Nat. Biotechnol. 2009, 27:753-U107.
14. Duetz W.A., Bouwmeester H., van Beilen J.B., Witholt B. Biotransformation of limonene by bacteria, fungi, yeasts, and plants. Appl. Microbiol. Biotechnol. 2003, 61:269-277.
15. Dunlop M.J., Dossani Z.Y., Szmidt H.L., Chu H.C., Lee T.S., Keasling J.D., Hadi M.Z., Mukhopadhyay A. Engineering microbial biofuel tolerance and export using efflux pumps. Mol. Syst. Biol. 2011, 7:487.
16. Farmer W.R., Liao J.C. Improving lycopene production in Escherichia coli by engineering metabolic control. Nat. Biotechnol. 2000, 18:533-537.
17. Gelb M.H., Tamanoi F., Yokoyama K., Ghomashchi F., Esson K., Gould M.N. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett. 1995, 91:169-175.
18. Gould M.N. Cancer chemoprevention and therapy by monoterpenes. Environ. Health Perspect. 1997, 105:977-979.
19. Hanahan D. Studies on transformation of Escherichia coli with plasmids. Journal of molecular biology 1983, 166:557-580.
20. Hyatt D.C., Youn B.Y., Zhao Y.X., Santhamma B., Coates R.M., Croteau R.B., Kang C.H. Structure of limonene synthase, a simple model for terpenoid cyclase catalysis. Proc. Nat. Acad. Sci. USA 2007, 104:5360-5365.
21. Keasling J.D. Manufacturing Molecules Through Metabolic Engineering. Science 2010, 330:1355-1358.
22. Lee T.S., Krupa R.A., Zhang F., Hajimorad M., Holtz W.J., Prasad N., Lee S.K., Keasling J.D. BglBrick vectors and datasheets: a synthetic biology platform for gene expression. J. Biol. Eng. 2011, 5:12.
23. Ma S.M., Garcia D.E., Redding-Johanson A.M., Friedland G.D., Chan R., Batth T.S., Haliburton J.R., Chivian D., Keasling J.D., Petzold C.J., Lee T.S., Chhabra S.R. Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. Metab. Eng. 2011, 13:588-597.
24. MacLean B., Tomazela D.M., Shulman N., Chambers M., Finney G.L., Frewen B., Kern R., Tabb D.L., Liebler D.C., MacCoss M.J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26:966-968.
25. Mars A.E., Gorissen J.P.L., van den Beld I., Eggink G. Bioconversion of limonene to increased concentrations of perillic acid by Pseudomonas putida GS1 in a fed-batch reactor. Appl. Microbiol. Biotechnol. 2001, 56:101-107.
26. Martin V.J.J., Pitera D.J., Withers S.T., Newman J.D., Keasling J.D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 2003, 21:796-802.
27. Mirata Antonio M., Heerd Doreen, Schrader Jens Integrated bioprocess for the oxidation of limonene to perillic acid with Pseudomonas putida DSM 12264. Process Biochem. 2009, 44:8.
28. Misawa N. Pathway engineering for functional isoprenoids. Curr. Opin. Biotechnol. 2011, 22:627-633.
29. Moon T.S., Dueber J.E., Shiue E., Prather K.L.J. Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli. Metab. Eng. 2010, 12:298-305.
30. Peralta-Yahya P.P., Ouellet M., Chan R., Mukhopadhyay A., Keasling J.D., Lee T.S. Identification and microbial production of a terpene-based advanced biofuel. Nat. Commun. 2011, 483, 2.
31. Pitera D.J., Paddon C.J., Newman J.D., Keasling J.D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 2007, 9:193-207.
32. Redding-Johanson A.M., Batth T.S., Chan R., Krupa R., Szmidt H.L., Adams P.D., Keasling J.D., Lee T.S., Mukhopadhyay A., Petzold C.J. Targeted proteomics for metabolic pathway optimization: application to terpene production. Metab. Eng. 2011, 13:194-203.
33. Reiling K.K., Yoshikuni Y., Martin V.J.J., Newman J., Bohlmann J., Keasling J.D. Mono and diterpene production in Escherichia coli. Biotechnol. Bioeng. 2004, 87:200-212.
34. Ro D.K., Paradise E.M., Ouellet M., Fisher K.J., Newman K.L., Ndungu J.M., Ho K.A., Eachus R.A., Ham T.S., Kirby J., Chang M.C., Withers S.T., Shiba Y., Sarpong R., Keasling J.D. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943.
35. Rozkov A., Avignone-Rossa C.A., Ertl P.F., Jones P., O'Kennedy R.D., Smith J.J., Dale J.W., Bushell M.E. Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence. Biotechnol. Bioeng. 2004, 88:909-915.
36. Ryder, J.A., 2009. Jet Fuel Compositions. In: Amyris Biotechnologies, I. E., CA, US, (Ed.), United States.
37. Silva J.C., Gorenstein M.V., Li G.Z., Vissers J.P., Geromanos S.J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol. Cell. Proteomics: MCP 2006, 5:144-156.
38. Tracy N.I., Chen D.C., Crunkleton D.W., Price G.L. Hydrogenated monoterpenes as diesel fuel additives. Fuel 2009, 88:2238-2240.
39. Tsuruta H., Paddon C.J., Eng D., Lenihan J.R., Horning T., Anthony L.C., Regentin R., Keasling J.D., Renninger N.S., Newman J.D. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. Plos One 2009, 4.
40. Tyo K.E., Ajikumar P.K., Stephanopoulos G. Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nat. Biotechnol. 2009, 27:760-765.
41. van Beilen J.B., Holtackers R., Luscher D., Bauer U., Witholt B., Duetz W.A. Biocatalytic production of perillyl alcohol from limonene by using a novel Mycobacterium sp cytochrome P450 alkane hydroxylase expressed in Pseudomonas putida. Appl. Environ. Microbiol. 2005, 71:1737-1744.
42. Wagner K.H., Elmadfa I. Biological relevance of terpenoids-overview focusing on mono-, di- and tetraterpenes. Ann. Nutr. Metab. 2003, 47:95-106.
43. Wang C., Yoon S.H., Jang H.J., Chung Y.R., Kim J.Y., Choi E.S., Kim S.W. Metabolic engineering of Escherichia coli for alpha-farnesene production. Metab. Eng. 2011, 13:648-655.
44. Yoon S.H., Lee S.H., Das A., Ryu H.K., Jang H.J., Kim J.Y., Oh D.K., Keasling J.D., Kim S.W. Combinatorial expression of bacterial whole mevalonate pathway for the production of beta-carotene in E. coli. J. Biotechnol. 2009, 140:218-226.